| Antigen-specific immunotherapy for treatment of autoimmune liver diseases N Richardson, STH Ng, DC Wraith Frontiers in immunology 11, 545348, 2020 | 30 | 2020 |
| Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease N Richardson, GE Wootton, AG Bozward, YH Oo Seminars in immunopathology 44 (4), 461-474, 2022 | 28 | 2022 |
| Bidirectional cross-talk between biliary epithelium and Th17 cells promotes local Th17 expansion and bile duct proliferation in biliary liver diseases HC Jeffery, S Hunter, EH Humphreys, R Bhogal, RE Wawman, J Birtwistle, ... The Journal of Immunology 203 (5), 1151-1159, 2019 | 26 | 2019 |
| Advancement of antigen-specific immunotherapy: knowledge transfer between allergy and autoimmunity N Richardson, DC Wraith Immunotherapy Advances 1 (1), ltab009, 2021 | 10 | 2021 |
| Expression of E-cadherin by CD8+ T cells promotes their invasion into biliary epithelial cells SP Davies, V Ronca, GE Wootton, NM Krajewska, AG Bozward, ... Nature Communications 15 (1), 853, 2024 | 1 | 2024 |
| OS-046 Features of regulatory T cells in primary biliary cholangitis N Richardson, G Wootton, YH Oo Journal of Hepatology 80, S34-S35, 2024 | | 2024 |
| SAT-546 Elevated IL18R+ CD8+ T cells in Autoimmune Hepatitis patients are associated with a worse therapy response K Yankouskaya, I Allabauer, G Wootton, N Richardson, A Bozward, ... Journal of Hepatology 80, S356-S357, 2024 | | 2024 |
| Induced regulatory T cells via cyclin-dependent kinase inhibition from patients with primary biliary cholangitis are suppressive and stable in an IFN enriched environment and … V Ronca, K Kayani, SP Davies, M Arai, Y Nakamura, N Okamoto, ... Digestive and Liver Disease 56, S19-S20, 2024 | | 2024 |
| INDUCED REGULATORY T CELLS VIA CYCLIN-DEPENDENT KINASE INHIBITION FROM PATIENTS WITH PRIMARY BILIARY CHOLANGITIS ARE SUPPRESSIVE AND STABLE IN AN INTERFERON ENRICHED … V Ronca, K Kayani, S Davies, M Arai, Y Nakamura, N Okamoto, N Mikami, ... HEPATOLOGY 78, S2055-S2056, 2023 | | 2023 |
| Production of reactive oxidant species and fatty acid uptake is increased in regulatory T-cells in autoimmune hepatitis, and associated with down-regulation of markers linked … S Davies, N Richardson, G Wootton, YH Oo, P Trivedi Journal of Hepatology 78, S416, 2023 | | 2023 |
| Developing highly pure, functional GMP grade Treg for the treatment of autoimmune liver disease N Richardson, G Wootton, A Bozward, YH Oo Journal of Hepatology 78, S443-S444, 2023 | | 2023 |
| Epigenetic conversion of CD4+ T cells to stable and functioning induced regulatory T cells via cyclin-dependent kinase inhibition and CD28 signal deprivation in patients with … V Ronca, S Davies, K Kayani, N Mikami, M Arai, Y Nakamura, N Okamoto, ... Journal of Hepatology 78, S447-S448, 2023 | | 2023 |
| P41 Conversion of CD4+ T cells to functioning and epigenetically stable induced regulatory T cells in patients with primary biliary cholangitis K Kayani, V Ronca, M Arai, Y Nakamura, N Okamoto, N Mikami, N Ohkura, ... Gut 72 (Suppl 2), A67-A67, 2023 | | 2023 |
| Expression of E-cadherin by large CD103+ CD69+ CD8+ T cells promotes their invasion into biliary epithelial cells S Davies, V Ronca, G Wootton, A Bozward, R Fiancette, G Reynolds, ... | | 2023 |
| Antigen-specific immunotherapy: identification of T cell epitopes in autoimmune hepatitis type 2 and characterisation of bystander suppression mechanisms N Richardson University of Birmingham, 2021 | | 2021 |
| Developing antigen-specific immunotherapy for autoimmune hepatitis type 2 by identification of T cell epitopes N Richardson, S Warner, V Ronca, D Kelly, YH Oo, D Wraith Journal of Hepatology 73, S202, 2020 | | 2020 |
